Suppression of human prostate carcinoma metastases in severe combined immunodeficient mice by interleukin 2 immunocytokine therapy

Clinical Cancer Research

Volumn 4, Issue 10, 1998, Pages 2551-2557

  Dolman, Carrie S ^a   Mueller, Barbara M ^a   Lode, Holger N ^a   Xiang, Rong ^a   Gillies, Stephen D ^b   Reisfeld, Ralph A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Lexigen Pharmaceuticals Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW METASTASIS; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG METASTASIS; MALE; METASTASIS INHIBITION; MINIMAL RESIDUAL DISEASE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; SCID MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL ADHESION MOLECULES; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; PROSTATIC NEOPLASMS;

EID: 0031752493     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. American Cancer Society. Surveillance research. J. Natl. Cancer Inst., 90: 193, 1998.
2. Moody, D. B., Robinson, J. C., Ewing, C. M., Lazenby, A. J., and Isaacs, W. B. Interleukin-2 transfected prostate cancer cells generate a local antitumor effect in vivo. Prostate, 24: 244-251, 1994.
3. Vieweg, J., Rosenthal F. M., Bannerji, R., Heston, W. D., Fair, W. R., Gansbacher, B., and Gilboa, E. Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res., 54: 1760-1765, 1994.
4. Sanda, M. G., Ayyagari, S. R., Jaffee, E. M., Epstein, J. I., Clift, S. L., Cohen, L. K., Dranoff, G., Pardoll, D. M., Mulligan, R. C., and Simons, J. W. Demonstration of a rational strategy for human prostate cancer gene therapy. J. Urol., 151: 622-628, 1994.
5. Kwon, E. D., Hurwitz, A. A., Foster, B. A., Madias, C., Feldhaus, A. L., Greenberg, N. M., Burg, M. B., and Allison, J. P. Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc. Natl. Acad. Sci. USA, 94: 8099-8103, 1997.
6. Roth, J. A., and Cristiano, R. J. Gene therapy for cancers: what have we done and where are we going. J. Natl. Cancer Inst., 89: 21-39, 1997.
7. Becker, J. C., Pancook, J. D., Gillies, S. D., Furukawa, K., and Reisfeld, R. A. T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy. J. Exp Med 183: 2361-2366, 1996.
8. Xiang, R., Lode, H. N., Dolman, C. S., Dreier, T., Varki, N. M., Qian, X., Lo, K-M., Lan, Y., Super, M., Gillies, S. D., and Reisfeld, R. A. Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy. Cancer Res., 57: 4948-4955, 1997.
9. Lode, H. N., Xiang, R., Varki, N. M., Dolman, C. S., Gillies, S. D., and Reisfeld, R. A. Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow. J. Natl Cancer Inst., 89: 1586-1594, 1997.
10. Lode, H. N., Xiang, R., Dreier, T., Varki, N. M., Gillies, S. D., and Reisfeld, R. A. Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy. Blood, 91: 1706-1715, 1998.
11. Zhang, S., Zhang, H. S., Reuter, V. E., Slovin, S. F., Scher, H. I., and Livingston, P. O. Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers. Clin. Cancer Res., 4: 295-302, 1998.
12. Varki, N. M., Reisfeld, R. A., and Walker, L. E. Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies. Cancer Res., 44: 681-687, 1984.
13. Gillies, S. D., Lan, Y., Wesolowski, J. S., Quian, X., Reisfeld, R. A., Holden, F., Super, M., and Lo, K-M. Antibody-IL12 fusion proteins are effective in SCID mouse models of prostate and colon carcinoma metastases. J. Immunol., 160: 6195-6203, 1998.
14. Mueller, B. M., Reisfeld, R. A., and Gillies, S. D. Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2. Proc. Natl. Acad. Sci. USA, 87: 5702-5705, 1990.
15. Scatchard, O. The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci., 51: 660-669, 1949.
16. Tepper, R. I., Coffman, R. L., and Leder, P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science (Washington DC), 257: 548-551, 1992.
17. Conlan, J. W., and North, R. J. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J. Exp. Med., 179: 259-268, 1994.
18. Sanda, M. G., Restifo, N. P., Walsh, J. C., Kawakami, Y., Nelson, W. G., Pardoll, D. M., and Simons, J. W. Molecular characterization of defective antigen processing in human prostate cancer. J Natl Cancer Inst., 87: 280-285, 1995.